The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk pending more data on everyone else — raising questions about whether some people who want a vaccine this fall will be able to get one.
U.S. advocacy groups are waging an intensive campaign to protect Medicaid and Obamacare from Donald Trump's 'big, beautiful bill', after House Republicans proposed an $880 billion cut that could leave an estimated 13 million Americans without health insurance.
The GOP megabill is undergoing some significant changes in the House as conservative hard-liners, moderates and blue-state Republicans all angle to shape the bill to their liking ahead of a potential floor vote this week.
While lawsuits continue to be filed against companies alleging their management of forfeited funds in 401(k) plans violates their duties under the Employee Retirement Income Security Act, another company has reached a settlement agreement. The Cigna Group is the latest company to face a lawsuit over its treatment of forfeitures. Meanwhile, software company Intuit Inc. has reached a settlement after the court had allowed the case to continue in 2024.
After Donald Trump signed an executive order slashing drug prices last week, experts have highlighted how PBMs could be hit the hardest despite pharmaceutical companies facing the potential of compressed margins amid poor pricing power.
After Arkansas Blue Cross & Blue Shield's worst financial loss ever and forecasts of more red ink this year, President and CEO Curtis Barnett is facing an inflection point in the health industry head-on. ABCBS has been a mainstay in Arkansas health care for 77 years. After a $226.2 million loss in 2024, Barnett is expecting a smaller loss in 2025.